Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-02

Clinical Trial Update: Accuracy of an Echo-Stress Protocol Using Regadenoson With Speckle Tracking [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the accuracy of an echocardiography stress test protocol using regadenoson with speckle-tracking imaging; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lexiscan (regadenoson)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Ischemia | Phase 4 | Status: COMPLETED | Results posted: 2024-10-02